CIBC Private Wealth Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$154K Sell
2,288
-603
-21% -$40.6K ﹤0.01% 1323
2025
Q3
$212K Buy
2,891
+329
+13% +$21.9K ﹤0.01% 1156
2025
Q2
$133K Sell
2,562
-1,484
-37% -$84.4K ﹤0.01% 1278
2025
Q1
$233K Buy
4,046
+993
+33% +$57.7K ﹤0.01% 1028
2024
Q4
$164K Sell
3,053
-963,451
-100% -$49.4M ﹤0.01% 1233
2024
Q3
$55.3M Buy
966,504
+962,575
+24,499% +$55.2M 0.1% 174
2024
Q2
$206K Buy
3,929
+1,046
+36% +$45.9K ﹤0.01% 1086
2024
Q1
$119K Buy
+2,883
New +$108K ﹤0.01% 1317
2023
Q1
Sell
-26,239
Closed -$1.49K 905
2022
Q4
$1.49K Buy
+26,239
New +$1.34M ﹤0.01% 761
2019
Q4
Sell
-21,723
Closed -$337K 909
2019
Q3
$337K Hold
21,723
﹤0.01% 761
2019
Q2
$373K Sell
21,723
-6,212
-22% -$100K ﹤0.01% 773
2019
Q1
$450K Sell
27,935
-4,238
-13% -$68.7K ﹤0.01% 746
2018
Q4
$471K Buy
32,173
+1,941
+6% +$31K ﹤0.01% 694
2018
Q3
$549K Buy
30,232
+4,466
+17% +$78.2K ﹤0.01% 756
2018
Q2
$435K Buy
25,766
+3,541
+16% +$67K ﹤0.01% 802
2018
Q1
$435K Sell
22,225
-576
-3% -$11.2K ﹤0.01% 808
2017
Q4
$462K Sell
22,801
-2,917
-11% -$53.6K ﹤0.01% 795
2017
Q3
$447K Sell
25,718
-907
-3% -$12.3K ﹤0.01% 787
2017
Q2
$341K Buy
26,625
+1,615
+6% +$21.6K ﹤0.01% 572
2017
Q1
$324K Hold
25,010
﹤0.01% 555
2016
Q4
$247K Buy
25,010
+4,310
+21% +$47.2K ﹤0.01% 569
2016
Q3
$250K Buy
+20,700
New +$212K ﹤0.01% 569
2016
Q1
Sell
-17,985
Closed -$312K 587
2015
Q4
$312K Buy
17,985
+1,270
+8% +$20.2K ﹤0.01% 561
2015
Q3
$224K Sell
16,715
-3,910
-19% -$78.5K ﹤0.01% 590
2015
Q2
$466K Buy
20,625
+1,855
+10% +$32.6K ﹤0.01% 560
2015
Q1
$268K Buy
+18,770
New +$271K ﹤0.01% 592

Other funds holding HALO

CIBC Private Wealth Group's HALO Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Halozyme (HALO) stake by 21% in Q4 2025, selling an estimated $40.6K and leaving 2,288 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #1323.

CIBC Private Wealth Group first reported a position in HALO in Q1 2015 and has held it in 26 quarters since. The position peaked at $55.3M in Q3 2024. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • CIBC Private Wealth Group held 2,288 shares of Halozyme worth $154K as of Q4 2025.
  • CIBC Private Wealth Group sold 603 Halozyme shares in Q4 2025, an estimated $40.6K.
  • Halozyme made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1323 holding.
  • CIBC Private Wealth Group first reported a position in Halozyme in Q1 2015 and has held it in 26 quarters since.
  • CIBC Private Wealth Group's Halozyme position peaked at $55.3M in Q3 2024.
  • 617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.